Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-23

Clinical Trial Update: STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 STABIL study updates Mircera's effectiveness in maintaining hemoglobin levels in dialysis patients; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-06-23